XRCC2 has an important role in repair of DNA damage by homologous recombination. Adult Apc min/+ (min, multiple intestinal neoplasia) mice, wild-type or heterozygous for Xrcc2 deficiency, were sham-irradiated or 2-Gy X-irradiated. Spontaneous mammary and intestinal tumor incidences are lower in Apc min/+ Xrcc2 +/− mice than in Apc min/+ Xrcc2 +/+ mice (mammary tumors: 14% and 38%, respectively, χ 2 P = 0.03; intestinal adenomas in mice reaching full life span: 108.6 and 130.1, respectively, t-test P = 0.005). Following irradiation, the increase in mammary tumors was greatest in female mice heterozygous for Xrcc2 (7.25 ± 0.50-fold in Apc min/+ Xrcc2 +/− mice compared with 2.57 ± 0.35-fold in Apc min/+ Xrcc2 +/+ mice; t-test P < 0.001). The increase in intestinal tumor multiplicity following irradiation was significantly greater in Apc min/+ Xrcc2 +/− mice (Apc min/+ Xrcc2 +/− , 4.14 ± 0.05-fold, versus Apc min/+ Xrcc2 +/+ , 3.30 ± 0.05-fold; t-test P < 0.001). Loss of heterozygosity of all chromosome 18 markers was greater in intestinal tumors from Apc min/+ Xrcc2 +/− mice than in tumors from Apc min/+ Xrcc2 +/+ mice. These findings indicate that Xrcc2 haploinsufficiency reduces spontaneous tumor incidence on an Apc min/+ background but increases the tumorigenic response to radiation. Mol Cancer Res; 8(9); 1227-33. ©2010 AACR.